Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Loricrin (LOR) Peptide

LOR Reactivité: Mammifères Hôte: Synthetic BP, IHC, WB
N° du produit ABIN939071

Aperçu rapide pour Loricrin (LOR) Peptide (ABIN939071)

Antigène

LOR (Loricrin (LOR))

Origine

Mammifères

Source

  • 1
Synthetic

Application

Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
  • Type de proteíne

    Synthetic

    Séquence

    GYSGGGCGGG SSGGGGGGGI GGCGGGSGGS VKYSGGGGSS GGGSGCFSSG

    Attributs du produit

    A synthetic peptide for use as a blocking control in assays to test for specificity of LOR antibody,
    Alternative Names: Loricrin control peptide, Loricrin antibody Blocking Peptide, Anti-Loricrin Blocking Peptide, MGC111513 Blocking Peptide, LOR Blocking Peptide
  • Indications d'application

    Optimal conditions should be determined by the investigator

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.

    Buffer

    PBS

    Conseil sur la manipulation

    Avoid repeated freeze/thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20 °C long term.
  • Antigène

    LOR (Loricrin (LOR))

    Classe de substances

    Chemical

    Sujet

    LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.

    Poids moléculaire

    35 kDa
Vous êtes ici:
Chat with us!